Apptly Announces $1,000,000 Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company") is pleased to announce that it intends to complete a non-brokered private placement of up to 8,000,000 units of the Company (the "Units"), at a price of $0.125 per Unit, for aggregate gross proceeds of up to $1,000,000 (the "Offering"). The Company reserves the right to increase the size of the Offering in its sole discretion. Th
2026-08-24 8:00 PM EDT | Apptly Health Technologies Corp.
LevelJump Announces Q2 Record Revenue
Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the second quarter ended June 30, 2026. The Company, through its CTS and ADC operations, had a strong quarter as demand continued increasing for our services. Our current focus remains on organic growth, expansion of services, and maximizing revenue opportunities. Financial and Operationa
Healthcare and Hospitals, Health
2026-08-24 7:30 PM EDT | LevelJump Healthcare Corp.
BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - BetterLife Pharma Inc. (CSE: BETR) ("BetterLife" or the "Company"), a biotechnology company developing treatments for neurological disorders, announced today that it has filed a preliminary short form prospectus (the "Preliminary Prospectus") with the securitie
2026-08-24 6:42 PM EDT | BetterLife Pharma Inc.
Tersis Technologies and Ameri-Green Environmental Recycling Sign MOU for First Planned U.S. Commercial Deployment of SynGenic V3 Technology
Brooksville, Florida--(Newsfile Corp. - August 24, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company") today announced that it has entered into a Memorandum of Understanding ("MOU") with Ameri-Green Environmental Recycling, LLC ("Ameri-Green") establishing a framework for the parties to pursue a joint venture focused on the deployment and commercialization of Tersis' SynGenic V3 resource-recovery technology in Americus, Georgia.
Agriculture, Energy, Alternative Energy, Health
2026-08-24 11:11 AM EDT | Tersis Technologies Inc.
NorthPalm Commits Entire Cybeats Position to a 12-Month Lock-Up; 60 Million Shares Representing Approximately 30% of Cybeats
Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - NorthPalm Capital Corp. (CSE: NP) ("NorthPalm" or the "Company"), is pleased to announce that it has committed to a 12-month lock-up of its entire remaining position of 60,000,000 common shares of Cybeats Technologies Corp. (CSE: CYBT) ("Cybeats"), representing approximately 30% of Cybeats' outstanding shares. NorthPalm remains the largest institutional shareholder of Cybeats and is committed to maintaining a signif
Biotechnology, Healthcare and Hospitals, Health
2026-08-24 9:39 AM EDT | NorthPalm Capital Corp.
Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting
Winter Park, Florida--(Newsfile Corp. - August 24, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced that it has entered into an engagement letter with Lucosky Brookman LLP ("Lucosky Brookman") to act as legal counsel in connection with the Company's planned uplisting from the OTC Markets to the NASDAQ Capital Market.
Healthcare and Hospitals, Health
2026-08-24 8:00 AM EDT | Adia Med Inc.
Promino Secures 662-Store Kroger Pharmacy Test for Rejuvenate Muscle Health(TM)
Burlington, Ontario--(Newsfile Corp. - August 24, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company") is pleased to announce that Rejuvenate Muscle Health™ Raspberry Burst 14-count will launch in 662 Kroger stores as part of a 90-day pharmacy test focused on consumers using GLP-1 medications for weight management. Kroger has issued the initial purchase order, with product expected on shelves in participating stor
Food / Beverages, Sports, Health
2026-08-24 7:00 AM EDT | Promino Nutritional Sciences, Inc.
Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTA
Calgary, Alberta--(Newsfile Corp. - August 20, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is plea
Biotechnology, Pharmaceuticals, Health
2026-08-20 9:44 AM EDT | Hemostemix Inc.
Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy
Burlington, Ontario--(Newsfile Corp. - August 20, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in innovative oral thin film drug delivery technology, today announced that, together with its development partner Aavishkar Oral Strips Pvt. Ltd. ("Aavishkar"), have been granted a second key patent covering its QuickStrip™ nicotine oral-film technology. The Patent Office, Government of India has
2026-08-20 8:30 AM EDT | Rapid Dose Therapeutics Corp.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease Trial Design
Collaboration looks to explore the use of Darmiyan's FDA De Novo authorized BrainSee® imaging platform, authorized for predicting risk of progression to Alzheimer's disease in patients with amnestic mild cognitive impairment, as well as Darmiyan's core technology, the Virtual Microscope, tailored towards use in pharmaceutical clinical trials The goal of the collaboration is to inform the identification, selection and monitoring of the best candidates for cli
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-20 7:39 AM EDT | Rhelion Life Sciences Corp.
TempraMed Announces Extension of Maccabi Healthcare Services Agreement
Toronto, Ontario--(Newsfile Corp. - August 20, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator focused on temperature-sensitive medication protection, is pleased to announce that Maccabi Healthcare Services ("Maccabi"), Israel's second-largest health maintenance organization ("HMO"), has exercised its option to extend its agreement with TempraMed for an additional year u
Technology, Biotechnology, Pharmaceuticals, Health
2026-08-20 7:00 AM EDT | TempraMed Technologies Ltd.
WELL Health Redeems $70 Million 5.50% Convertible Debentures
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, r
Technology, Computer Software, Healthcare and Hospitals, Health
2026-08-20 6:30 AM EDT | WELL Health Technologies Corp.
Rise Nano Optics Joins the Vision Council, a Leading Optical Trade Association, Expanding Access to Key Optical Relationship
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, is pleased to announce that it has joined The Vision Council, one of the optical industry's leading trade associations representing hundreds of eyewear manufacturers, lens laboratories, retailers, distributors and technology c
2026-08-20 3:00 AM EDT | Rise Nano Optics Ltd.
Relief AI Inc. Announces Closing of Brokered Private Placement of Subscription Receipts
Toronto, Ontario--(Newsfile Corp. - August 19, 2026) - Relief AI Inc. ("Relief AI" or the "Company") and 1329308 B.C. Ltd. ("132 BC") jointly announce that, further to the joint press releases of July 6, 2026 and July 30, 2026, the Company has closed its "best efforts" brokered private placement through the issuance of 5,723,900 subscription receipts of the Company (each, a "Subscription Receipt") at a price of $1.00 per Subscription Receipt (the "Offering Price
Technology, Healthcare and Hospitals, Health
2026-08-19 9:09 AM EDT | Relief AI Inc.
Obesity Medicine Association Announced as Primary Educational Partner of the American Board of Obesity Medicine
Denver, Colorado--(Newsfile Corp. - August 19, 2026) - The Obesity Medicine Association (OMA) is honored to announce that they have been named one of the first Primary Educational Partners (PEPs) of the American Board of Obesity Medicine (ABOM). PEPs are organizations approved by ABOM to offer Core Obesity Medicine CME credit to physicians applying for obesity medicine certification through their Continuing Medical Education (CME) pathway. The partnership program was designed as
Healthcare and Hospitals, Health
2026-08-19 9:00 AM EDT | Obesity Medicine Association
Rhelion Life Sciences Announces Appointment of Samiuddin Khaja as CFO
Toronto, Ontario--(Newsfile Corp. - August 19, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to announce the appointment of Samiuddin Khaja as Chief Financial Officer ("CFO") effective immediately. The appointment comes as Rhelion continues its evolution into a focused, research-led life sciences company following the a
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-19 8:14 AM EDT | Rhelion Life Sciences Corp.
BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), a biotechnology company developing treatments for neurological disorders, today announced the appointment of Mahan Chehrenama, DO, as Chief Medical Officer. Dr. Chehrenama will lead clinical development for BETR-001, the Company's non-hallucinogenic neuroplastogen advancing toward an Investigational New Drug (IND) appli
2026-08-19 8:00 AM EDT | BetterLife Pharma Inc.
Charlotte's Web Launches Route CBD to Support Californians Who Depend on Full-Spectrum Hemp CBD
Louisville, Colorado--(Newsfile Corp. - August 19, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp extract wellness products, today announced the launch of Route CBD, a multi-city advocacy initiative designed to create access and raise awareness of the growing crisis facing Californians who have lost access to trusted full spectrum hemp CBD products.
2026-08-19 7:07 AM EDT | Charlotte's Web Holdings, Inc.
FloraWorks Advances Patented TruCBN(TM) Platform with Peer-Reviewed Safety Publication and Internal GRAS Conclusion
Portland, Oregon--(Newsfile Corp. - August 18, 2026) - FloraWorks Holdings Inc. ("FloraWorks") today announced significant new scientific and regulatory milestones for TruCBN™, its proprietary high-purity cannabinol (CBN) ingredient, further advancing the company's patented CBN platform. TruCBN™ is produced from hemp-derived CBD using FloraWorks' patented controlled oxidation process, protected under U.S. Patent No. 12,371,412 B2. CBN forms naturally in hemp through o
Technology, Cannabis, Health, Cannabis Manufacturer
2026-08-18 11:00 AM EDT | FloraWorks
TempraMed Executes Definitive Exclusive Distribution Agreement with TEM in Panama, Advancing Commercial Expansion Across Clinics and Pharmacies
Toronto, Ontario--(Newsfile Corp. - August 18, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9
Technology, Biotechnology, Pharmaceuticals, Health
2026-08-18 7:00 AM EDT | TempraMed Technologies Ltd.